JP2023506750A5 - - Google Patents
Info
- Publication number
- JP2023506750A5 JP2023506750A5 JP2022535429A JP2022535429A JP2023506750A5 JP 2023506750 A5 JP2023506750 A5 JP 2023506750A5 JP 2022535429 A JP2022535429 A JP 2022535429A JP 2022535429 A JP2022535429 A JP 2022535429A JP 2023506750 A5 JP2023506750 A5 JP 2023506750A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025064328A JP2025111508A (ja) | 2019-12-11 | 2025-04-09 | Ltbr及びedb結合ドメインを含む多重特異性結合分子並びにその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946452P | 2019-12-11 | 2019-12-11 | |
| US62/946,452 | 2019-12-11 | ||
| PCT/EP2020/085623 WO2021116337A1 (en) | 2019-12-11 | 2020-12-10 | Multispecific binding molecules comprising ltbr and edb binding domains and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025064328A Division JP2025111508A (ja) | 2019-12-11 | 2025-04-09 | Ltbr及びedb結合ドメインを含む多重特異性結合分子並びにその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023506750A JP2023506750A (ja) | 2023-02-20 |
| JP2023506750A5 true JP2023506750A5 (cg-RX-API-DMAC7.html) | 2023-11-20 |
| JP7837867B2 JP7837867B2 (ja) | 2026-03-31 |
Family
ID=74104042
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535429A Active JP7837867B2 (ja) | 2019-12-11 | 2020-12-10 | Ltbr及びedb結合ドメインを含む多重特異性結合分子並びにその使用 |
| JP2025064328A Pending JP2025111508A (ja) | 2019-12-11 | 2025-04-09 | Ltbr及びedb結合ドメインを含む多重特異性結合分子並びにその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025064328A Pending JP2025111508A (ja) | 2019-12-11 | 2025-04-09 | Ltbr及びedb結合ドメインを含む多重特異性結合分子並びにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210188990A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4073111A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7837867B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220130687A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115087670B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020401755A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3164226A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL293742A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021116337A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115677851B (zh) * | 2021-07-29 | 2024-03-22 | 东莞市朋志生物科技有限公司 | 一种免疫阻断抗体或其抗原结合片段及其应用 |
| CR20240246A (es) * | 2021-12-20 | 2024-07-19 | Hoffmann La Roche | Anticuerpos agonistas anti-ltbr y anticuerpos biespecificos que los comprenden |
| US20250235534A1 (en) * | 2022-04-13 | 2025-07-24 | Vib Vzw | An LTBR Agonist In Combination Therapy Against Cancer |
| EP4551240A1 (en) | 2022-07-08 | 2025-05-14 | Viromissile, Inc. | Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof |
| JP2026523881A (ja) | 2023-07-07 | 2026-07-15 | メスタッグ セラピューティクス エルティーディー | 結合コンストラクト |
| EP4527851A1 (en) | 2023-09-22 | 2025-03-26 | Bayer Aktiengesellschaft | Bispecific antibodies binding ltbr and lrrc15 |
| IL328577A (en) | 2023-11-24 | 2026-07-01 | Medpacto Inc | Fusion protein that specifically binds to extradomain b of fibronectin (edb-fn) and transforming growth factor beta (tgfβ) and its use |
| WO2025172588A1 (en) | 2024-02-16 | 2025-08-21 | Mestag Therapeutics Ltd | Bispecific constructs directed against fap and ltbr |
| WO2025172587A1 (en) | 2024-02-16 | 2025-08-21 | Mestag Therapeutics Ltd | Binding constructs |
| WO2025221728A2 (en) | 2024-04-15 | 2025-10-23 | Janssen Biotech, Inc. | Ltbr binding molecules and uses thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9610967D0 (en) | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
| EP1259548A1 (en) * | 2000-02-24 | 2002-11-27 | Eidgenössische Technische Hochschule Zürich | Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| NZ525793A (en) | 2000-10-13 | 2008-04-30 | Biogen Idec Inc | Humanized anti-LT-beta-R antibodies |
| CN1678625A (zh) * | 2002-07-01 | 2005-10-05 | 比奥根艾迪克Ma公司 | 人源化抗淋巴毒素β受体的抗体 |
| RS20050481A (sr) * | 2002-12-20 | 2007-08-03 | Biogen Idec Ma Inc., | Agensi limfotoksin beta receptora u kombinaciji sa hemoterapeutskim agensima |
| CN100473664C (zh) | 2002-12-20 | 2009-04-01 | 拜奥根Idec马萨诸塞公司 | 多价淋巴毒素β受体激动剂及其治疗用途 |
| BRPI0509201A (pt) * | 2004-03-23 | 2007-08-28 | Biogen Idec Inc | agentes de acoplamento de receptor e usos terapêuticos destes |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| WO2006074399A2 (en) * | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| KR101374454B1 (ko) | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| EP1892248A1 (en) | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| US9067986B2 (en) | 2009-04-27 | 2015-06-30 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| TWI507525B (zh) | 2009-06-26 | 2015-11-11 | Regeneron Pharma | 具天然免疫球蛋白形式之易分離的雙專一性抗體 |
| CA2772162C (en) | 2009-08-27 | 2018-05-22 | Covagen Ag | Anti-il-17a fynomers and medical uses thereof |
| PT2560993T (pt) | 2010-04-20 | 2024-09-16 | Genmab As | Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| US9574010B2 (en) | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| EP2638916A1 (en) * | 2012-03-16 | 2013-09-18 | Covagen AG | Novel binding molecules with antitumoral activity |
| EP2825197B1 (en) | 2012-03-16 | 2018-06-06 | Covagen AG | Novel binding molecules with antitumoral activity |
| HK1214605A1 (zh) | 2013-04-19 | 2016-07-29 | Covagen Ag | 具有抗肿瘤活性的新颖的双特异性结合分子 |
| CN122399016A (zh) * | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| JP6894430B2 (ja) * | 2015-08-24 | 2021-06-30 | セレクティスCellectis | 統合された制御機能を有するキメラ抗原受容体 |
| WO2018119118A1 (en) | 2016-12-20 | 2018-06-28 | Oncomed Pharmaceuticals, Inc. | Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof |
| US20190100587A1 (en) | 2017-10-02 | 2019-04-04 | Covagen Ag | IgG1 Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONS |
| TW202120537A (zh) * | 2019-08-15 | 2021-06-01 | 美商健生生物科技公司 | 用於經改善的單鏈可變片段之材料及方法 |
-
2020
- 2020-12-10 WO PCT/EP2020/085623 patent/WO2021116337A1/en not_active Ceased
- 2020-12-10 CN CN202080096332.8A patent/CN115087670B/zh active Active
- 2020-12-10 JP JP2022535429A patent/JP7837867B2/ja active Active
- 2020-12-10 US US17/117,304 patent/US20210188990A1/en not_active Abandoned
- 2020-12-10 KR KR1020227023655A patent/KR20220130687A/ko active Pending
- 2020-12-10 EP EP20830098.8A patent/EP4073111A1/en active Pending
- 2020-12-10 CA CA3164226A patent/CA3164226A1/en active Pending
- 2020-12-10 AU AU2020401755A patent/AU2020401755A1/en active Pending
- 2020-12-10 IL IL293742A patent/IL293742A/en unknown
-
2024
- 2024-12-06 US US18/971,955 patent/US20250101123A1/en active Pending
-
2025
- 2025-04-09 JP JP2025064328A patent/JP2025111508A/ja active Pending